Perioperative Pembrolizumab Regimen Upholds Survival Benefit in Resectable NSCLC
“Key Takeaways: Pembrolizumab plus chemotherapy significantly improved 4-year OS and EFS in resectable early-stage NSCLC compared to chemotherapy alone. The pembrolizumab regimen showed a 27% reduction in mortality risk, with 4-year OS rates of 68.0% vs 56.7% for placebo.”
First Systemic Therapy Approved for Lung and Pancreatic Cancers With NRG1 Gene Fusions
“The U.S. Food and Drug Administration (FDA) has granted accelerated approval to zenocutuzumab-zbco (Bizengri) for the treatment of adult patients with advanced, unresectable, or metastatic non-small cell lung cancer (NSCLC) or pancreatic adenocarcinoma that harbors a gene fusion involving neuregulin 1 (NRG1). The drug is approved for use following disease progression during or after prior systemic therapy. “
FDA Grants Breakthrough Therapy Designation to Trodelvy for Small Cell Lung Cancer
“Key Takeaways: Trodelvy received Breakthrough Therapy designation for ES-SCLC after platinum-based chemotherapy, aiming to expedite its development and review. The phase 2 TROPiCS-03 study showed a 41.9% overall response rate for Trodelvy in ES-SCLC, with all responses being partial.”
MARIPOSA Trial Shows PFS Benefit With or Without CNS Disease in NSCLC
“During a Case-Based Roundtable® event, Joshua K. Sabari, MD, discussed the mechanism of action of amivantamab and the MARIPOSA trial in patients with EGFR-mutated non–small cell lung cancer in the first article of a 2-part series.”
Grammy Award-winning musician back on tour after beating lung cancer with UCI Health treatment
“ORANGE, Calif. (KABC) — After touring with Green Day for more than two decades, touring musician Jason Freese found himself stepping away from his passion to focus solely on beating lung cancer.”
AstraZeneca, Daiichi Sankyo withdraw EU application for lung cancer treatment
“AstraZeneca and Daiichi Sankyo have withdrawn their marketing authorisation application in the European Union (EU) voluntarily, intended for datopotamab deruxtecan (Dato-DXd), to treat advanced nonsquamous non-small cell lung cancer (NSCLC).”
Bridging the Gap: Telehealth Expands Access to Essential Palliative Care
“Palliative care plays a crucial role in improving the quality of life for patients with cancer and has proven benefits for patients and their caregivers, especially when integrated early in the treatment course.”
How a Never-Wavering Enthusiasm Changed Lung Cancer Care for the Better
“As a female leader in a competitive oncology field, Solange Peters, MD, PhD, pushed through the barriers— climbed over them—and completely transformed lung cancer care with her collaborative spirit.”
70s sitcom icon Linda Lavin dies age 87 after lung cancer diagnosis
“Star of sitcom Alice and Broadway icon Linda Lavin has died aged 87, confirms her representatives. Lavin, who started her career as a child stage actor, died unexpectedly on December 29 from complications linked to her recent lung cancer diagnosis.”
